These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 9196808)

  • 1. Reproducibility of p53 and Ki-67 immunoquantitation in Barrett's esophagus.
    Polkowski W; Meijer GA; Baak JP; ten Kate FJ; Obertop H; Offerhaus GJ; van Lanschot JJ
    Anal Quant Cytol Histol; 1997 Jun; 19(3):246-54. PubMed ID: 9196808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ki67 and p53 immunohistochemistry reduces interobserver variation in assessment of Barrett's oesophagus.
    Lörinc E; Jakobsson B; Landberg G; Veress B
    Histopathology; 2005 Jun; 46(6):642-8. PubMed ID: 15910595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computerized quantitative pathology for the grading of dysplasia in surveillance biopsies of Barrett's oesophagus.
    van Sandick JW; Baak JP; van Lanschot JJ; Polkowski W; ten Kate FJ; Obertop H; Offerhaus GJ
    J Pathol; 2000 Feb; 190(2):177-83. PubMed ID: 10657016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photodynamic therapy of Barrett's esophagus: ablation of Barrett's mucosa and reduction in p53 protein expression after treatment.
    Panjehpour M; Coppola D; Overholt BF; Vo-Dinh T; Overholt S
    Anticancer Res; 2008; 28(1B):485-9. PubMed ID: 18383889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical decision making in Barrett's oesophagus can be supported by computerized immunoquantitation and morphometry of features associated with proliferation and differentiation.
    Polkowski W; Baak JP; van Lanschot JJ; Meijer GA; Schuurmans LT; Ten Kate FJ; Obertop H; Offerhaus GJ
    J Pathol; 1998 Feb; 184(2):161-8. PubMed ID: 9602707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucin expression and proliferating cell index of esophageal Barrett's adenocarcinoma.
    Yamamoto S; Kijima H; Hara T; Chino O; Shimada H; Tanaka M; Inokuchi S; Makuuchi H
    Int J Mol Med; 2005 Sep; 16(3):375-80. PubMed ID: 16077942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of genetic changes in Barrett's adenocarcinoma and Barrett's esophagus by DNA in situ hybridization and immunohistochemistry.
    Krishnadath KK; Tilanus HW; Alers JC; Mulder AH; van Dekken H
    Cytometry; 1994 Feb; 15(2):176-84. PubMed ID: 8168405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant degeneration of Barrett's esophagus: the role of the Ki-67 proliferation fraction, expression of E-cadherin and p53.
    Feith M; Stein HJ; Mueller J; Siewert JR
    Dis Esophagus; 2004; 17(4):322-7. PubMed ID: 15569371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Barrett's dysplasia and the Vienna classification: reproducibility, prediction of progression and impact of consensus reporting and p53 immunohistochemistry.
    Kaye PV; Haider SA; Ilyas M; James PD; Soomro I; Faisal W; Catton J; Parsons SL; Ragunath K
    Histopathology; 2009 May; 54(6):699-712. PubMed ID: 19438745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Barrett's esophagus with CK7, CK20, p53, Ki67, and COX2 expressions using chromoendoscopical examination.
    Çoban Ş; Örmeci N; Savaş B; Ekiz F; Ensari A; Kuzu I; Palabıyıkoğlu M
    Dis Esophagus; 2013; 26(2):189-96. PubMed ID: 22591041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative immunohistochemistry using the CAS 200/486 image analysis system in invasive breast carcinoma: a reproducibility study.
    Makkink-Nombrado SV; Baak JP; Schuurmans L; Theeuwes JW; van der Aa T
    Anal Cell Pathol; 1995 Apr; 8(3):227-45. PubMed ID: 7547496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progression or regression of Barrett's esophagus--is it all in the eye of the beholder?
    Dekel R; Wakelin DE; Wendel C; Green C; Sampliner RE; Garewal HS; Martinez P; Fass R
    Am J Gastroenterol; 2003 Dec; 98(12):2612-5. PubMed ID: 14687805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical mucin expression of short-segment Barrett's esophagus.
    Yamamoto S; Kijima H; Hara T; Kenmochi T; Kise Y; Tanaka H; Chino O; Shimada H; Tanaka M; Inokuchi S; Makuuchi H
    Tokai J Exp Clin Med; 2003 Jul; 28(2):57-63. PubMed ID: 14714830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of the risk of adenocarcinoma in Barrett's esophagus by means of tumor markers (p53 and Ki67).
    Trakál E; Guidi A; Butti AL; Trakál JJ; Sambuelli R; Zárate FE
    Acta Gastroenterol Latinoam; 2010 Sep; 40(3):211-5. PubMed ID: 21049770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 expression in low grade dysplasia in Barrett's esophagus: correlation with interobserver agreement and disease progression.
    Skacel M; Petras RE; Rybicki LA; Gramlich TL; Richter JE; Falk GW; Goldblum JR
    Am J Gastroenterol; 2002 Oct; 97(10):2508-13. PubMed ID: 12385431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P53 and Ki-67 overexpression in gastroesophageal reflux disease--Barrett's esophagus and adenocarcinoma sequence.
    Binato M; Gurski RR; Fagundes RB; Meurer L; Edelweiss MI
    Dis Esophagus; 2009; 22(7):588-95. PubMed ID: 19302208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Narrow-band imaging with magnification in Barrett's esophagus: validation of a simplified grading system of mucosal morphology patterns against histology.
    Singh R; Anagnostopoulos GK; Yao K; Karageorgiou H; Fortun PJ; Shonde A; Garsed K; Kaye PV; Hawkey CJ; Ragunath K
    Endoscopy; 2008 Jun; 40(6):457-63. PubMed ID: 18459090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-grade dysplasia and superficial adenocarcinoma in Barrett's esophagus: histological mapping and expression of p53, p21 and Bcl-2 oncoproteins.
    Chatelain D; Fléjou JF
    Virchows Arch; 2003 Jan; 442(1):18-24. PubMed ID: 12536310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aneuploidy and overexpression of Ki67 and p53 as markers for neoplastic progression in Barrett's esophagus: a case-control study.
    Sikkema M; Kerkhof M; Steyerberg EW; Kusters JG; van Strien PM; Looman CW; van Dekken H; Siersema PD; Kuipers EJ
    Am J Gastroenterol; 2009 Nov; 104(11):2673-80. PubMed ID: 19638963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apoptosis and cell proliferation in the metaplasia-dysplasia-carcinoma-sequence of Barrett's esophagus.
    Halm U; Tannapfel A; Breitung B; Breidert M; Wittekind CW; Mössner J
    Hepatogastroenterology; 2000; 47(34):962-6. PubMed ID: 11020858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.